Furthermore, based on catecholamines’ established action mechanism of G signaling, which increases the cellular cAMP level, we believed that an adrenergic blocker could decrease cAMP levels and inhibit the UVR/cAMP/CREB signaling pathway, which is the main mechanism for UV-induced skin hyperpigmentation [36,37]. The gene discussed is CREB1; the disease is neoplasm.